Funder: Alzheimer's Drug Discovery Foundation
Due Dates: September 15, 2025 (Letter of Intent) | November 17, 2025 (Invited Full Proposal)
Funding Amounts: Up to $5,000,000 per award, multi-year duration, milestone-based payments
Summary: Supports IND-enabling studies and early-phase clinical trials for novel pharmacological interventions targeting Alzheimer's disease and related dementias.
Key Information: Focus on novel drug mechanisms related to biology of aging; anti-amyloid and cholinesterase inhibitor proposals not considered; clinical trials must register on ClinicalTrials.gov.